Drug Development Pharma - August 19, 2014
No investigation of Brilinta
The United States Department of Justice has announced that it closes its investigation into PLATO clinical trial for AstraZeneca’s Brilinta. In the PLATO study, Brilinta (ticagrelor) was compared to clopidrogel combined with acetylsalicylic acid. The studied showed that ticagrelor reduced cardiovascular events better than the rival. The Department of Justice started an investigation in October 2013 […]
Clinical Trials - August 19, 2014
Pledpharma reports result from new study
Futility analysis in PLIANT study completed and approved by the DSMB, states Pledpharma. The futility/safety analysis of the first 30 patients has been completed and that no negative impact on the anticancer effect of the chemotherapy drug has been observed. The analysis covers the first 30 patients in the study who have completed four treatment […]
Contract Services - August 18, 2014
Cobra Biologics expands production facility
The contract manufacturer Cobra Biologics are hiring new employees to the company’s production facility in Matfors in northern Sweden. In four years, the company has doubled its staff and in the spring of 2014 half a dozen employees were recruited. The company could have around 50 staff members in the fall, says local manager Lars […]
Clinical Trials - August 18, 2014
Hansa Medical reports positive results from phase II study
The Hansa Medical candidate drug IdeS has enabled successful kidney transplantation, reports the company. A successful kidney transplantation of an HLA sensitized patient has been accomplished following desensitization with the candidate drug IdeS at Uppsala University Hospital. “We have demonstrated, for the first time, that IdeS can enable transplantation for patients burdened by anti-HLA antibodies […]
Uncategorized - August 18, 2014
New technology offers insight into cholesterol
Advanced techniques developed by the Copenhagen Center for Glycomics at the University of Copenhagen makes it possible to study cells in greater detail than ever before. The findings have just been published in the Journal of Biological Chemistry and may, in the long term, improve the treatment of high cholesterol. The researchers have studied an important […]
MedTech Business - August 15, 2014
C-RAD gets UK order
The Uppsala company C-RAD received an order for the James Cook University Hospital in Middlesbrough, UK, for the C-RAD Catalyst System. The James Cook University Hospital in Middlesbrough will focus the use of the Catalyst System on the treatment of breast cancer patients, states C-RAD. The installation is scheduled for the fourth quarter of the fiscal year […]
